3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Sarcoma
2
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
28
Pheochromocytoma
11
Adrenocortical Carcinoma
11
Carcinoma, Neuroendocrine
10
Thyroid Neoplasms
9
Thyroid Cancer, Papillary
9
Pituitary Neoplasms
9
Sarcoma
7
Small Cell Lung Carcinoma
6
Paraganglioma
6
Neoplasms
6
Adrenal Gland Neoplasms
6
Parathyroid Neoplasms
5
Ovarian Neoplasms
5
Melanoma
5
Cholangiocarcinoma
5
Carcinoid Tumor
5
Pancreatic Neoplasms
4
Neuroblastoma
4
Multiple Endocrine Neoplasia Type 1
4
Insulinoma
4
Central Nervous System Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Osteosarcoma
3
Neoplasm Metastasis
3
Meningioma
3
Lung Neoplasms
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive
×
Endocrine
×
30 days
×
Clear all
NCT06881992
2026-05-18
Tumor HI
Rezolute
Phase 3
Recruiting
16 enrolled